Nicholas Investments Partners »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 1.1M 0.98
2023-09-30 $992k 1.1M 0.92

More positions owned by Nicholas Investments Partners

Monolithic Power Systems (MPWR)
Bwx Technologies (BWXT)
Celsius Hldgs Com New (CELH)
Exxon Mobil Corporation (XOM)
Evercore Class A (EVR)
Microsoft Corporation (MSFT)
Tfii Cn (TFII)
Lattice Semiconductor (LSCC)
MGIC Investment (MTG)
Digitalbridge Group Cl A New (DBRG)
Chevron Corporation (CVX)
Weatherford Intl Ord Shs (WFRD)
NVIDIA Corporation (NVDA)
Mirum Pharmaceuticals (MIRM)
Tanger Factory Outlet Centers (SKT)

View all positions for Nicholas Investments Partners

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Steelhead Partners
Calamos Advisors
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1